Prognostic significance of increased bone marrow microcirculation in newly diagnosed multiple myeloma: results of a prospective DCE-MRI study

[1]  D. Hose,et al.  Dynamic Contrast-Enhanced Magnetic Resonance Imaging for Assessment of Antiangiogenic Treatment Effects in Multiple Myeloma , 2014, Clinical Cancer Research.

[2]  G. Morgan,et al.  GUIDELINES FOR THE DIAGNOSIS AND MANAGEMENT OF MULTIPLE MYELOMA 2014 , 2014 .

[3]  K. Verstraete,et al.  The diagnostic value of SE MRI and DWI of the spine in patients with monoclonal gammopathy of undetermined significance, smouldering myeloma and multiple myeloma , 2014, European Radiology.

[4]  Junshik Hong,et al.  Magnetic resonance imaging pattern of bone marrow involvement as a new predictive parameter of disease progression in newly diagnosed patients with multiple myeloma eligible for autologous stem cell transplantation , 2014, British journal of haematology.

[5]  H. Goldschmidt,et al.  Infiltration patterns in monoclonal plasma cell disorders: correlation of magnetic resonance imaging with matched bone marrow histology. , 2014, European journal of radiology.

[6]  S. Steinberg,et al.  Bone marrow angiogenesis in myeloma and its precursor disease: a prospective clinical trial , 2014, Leukemia.

[7]  H. Goldschmidt,et al.  IMWG consensus on risk stratification in multiple myeloma , 2014, Leukemia.

[8]  M. Beksac,et al.  European Myeloma Network recommendations on the evaluation and treatment of newly diagnosed patients with multiple myeloma , 2014, Haematologica.

[9]  D. Hose,et al.  Progression in smoldering myeloma is independently determined by the chromosomal abnormalities del(17p), t(4;14), gain 1q, hyperdiploidy, and tumor load. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  G. Morgan,et al.  The impact of response on bone-directed therapy in patients with multiple myeloma. , 2013, Blood.

[11]  K. Verstraete,et al.  Value of whole body MRI and dynamic contrast enhanced MRI in the diagnosis, follow-up and evaluation of disease activity and extent in multiple myeloma. , 2013, European journal of radiology.

[12]  P. Sonneveld,et al.  Comparison of modern and conventional imaging techniques in establishing multiple myeloma‐related bone disease: a systematic review , 2013, British journal of haematology.

[13]  G. Morgan,et al.  International Myeloma Working Group recommendations for the treatment of multiple myeloma-related bone disease. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[14]  B. Barlogie,et al.  Prognostic implications of serial 18-fluoro-deoxyglucose emission tomography in multiple myeloma treated with total therapy 3. , 2013, Blood.

[15]  S. Rajkumar.  Multiple myeloma: 2013 update on diagnosis, risk‐stratification, and management , 2013, American journal of hematology.

[16]  P. L. Bergsagel,et al.  Management of newly diagnosed symptomatic multiple myeloma: updated Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) consensus guidelines 2013. , 2013, Mayo Clinic proceedings.

[17]  E. Zamagni,et al.  The role of imaging techniques in the management of multiple myeloma , 2012, British journal of haematology.

[18]  Bang-Bin Chen,et al.  Correlation among DCE‐MRI measurements of bone marrow angiogenesis, microvessel density, and extramedullary disease in patients with multiple myeloma , 2012, American journal of hematology.

[19]  H. Goldschmidt,et al.  Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) and diffusion-weighted imaging of bone marrow in healthy individuals , 2011, Acta radiologica.

[20]  Michael Dumiak.  National Center for Tumor Diseases, Heidelberg, Germany. , 2011, Architectural record.

[21]  M. Dimopoulos,et al.  Diffuse MRI marrow pattern correlates with increased angiogenesis, advanced disease features and poor prognosis in newly diagnosed myeloma treated with novel agents , 2010, Leukemia.

[22]  G. Brix,et al.  Simulation-based comparison of two approaches frequently used for dynamic contrast-enhanced MRI , 2010, European Radiology.

[23]  Robert A Kyle,et al.  Management of newly diagnosed symptomatic multiple myeloma: updated Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) consensus guidelines. , 2009, Mayo Clinic proceedings.

[24]  C. Claussen,et al.  Pathologic fractures in patients with multiple myeloma undergoing bisphosphonate therapy: incidence and correlation with course of disease. , 2009, AJR. American journal of roentgenology.

[25]  T. Rème,et al.  Induction of angiogenesis by normal and malignant plasma cells. , 2009, Blood.

[26]  H. Kauczor,et al.  Dynamic Contrast-Enhanced Magnetic Resonance Imaging Identifies a Subgroup of Patients with Asymptomatic Monoclonal Plasma Cell Disease and Pathologic Microcirculation , 2009, Clinical Cancer Research.

[27]  H. Kauczor,et al.  Gain of 1q21 and distinct adverse cytogenetic abnormalities correlate with increased microcirculation in multiple myeloma , 2008, International journal of cancer.

[28]  L. Vlahos,et al.  Differences in perfusion parameters between upper and lower lumbar vertebral segments with dynamic contrast-enhanced MRI (DCE MRI) , 2008, European Radiology.

[29]  K. Moriyama,et al.  Myeloma Cell-Osteoclast Interaction Enhances Angiogenesis Together with Bone Resorption: A Role for Vascular Endothelial Cell Growth Factor and Osteopontin , 2007, Clinical Cancer Research.

[30]  H. Kauczor,et al.  Lumbar Bone Marrow Microcirculation Measurements from Dynamic Contrast-Enhanced Magnetic Resonance Imaging Is a Predictor of Event-Free Survival in Progressive Multiple Myeloma , 2007, Clinical Cancer Research.

[31]  Shaji K. Kumar,et al.  Bone marrow angiogenic ability and expression of angiogenic cytokines in myeloma: evidence favoring loss of marrow angiogenesis inhibitory activity with disease progression. , 2004, Blood.

[32]  Santhosh K. P. Kumar,et al.  Prognostic value of bone marrow angiogenesis in patients with multiple myeloma undergoing high-dose therapy , 2004, Bone Marrow Transplantation.

[33]  R. Fonseca,et al.  Bone marrow angiogenesis in 400 patients with monoclonal gammopathy of undetermined significance, multiple myeloma, and primary amyloidosis. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[34]  G. van Kaick,et al.  Bone marrow microcirculation analysis in multiple myeloma by contrast‐enhanced dynamic magnetic resonance imaging , 2001, International journal of cancer.

[35]  R. Coleman.  Metastatic bone disease: clinical features, pathophysiology and treatment strategies. , 2001, Cancer treatment reviews.

[36]  R. Fonseca,et al.  Prognostic value of bone marrow angiogenesis in multiple myeloma. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.